Paper30008323
EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.
Zingg D and 17 others. Cancer Cell, 2018. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation. Papers, record 30008323. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30008323
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Movement | Major topic |
| Cell Proliferation | Major topic |
| Cilia | Major topic |
| Enhancer of Zeste Homolog 2 Protein | Major topic |
| Melanocytes | Major topic |
| Melanoma | Major topic |
| Skin Neoplasms | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Transformation, Neoplastic | |
| Female | |
| GTP Phosphohydrolases | |
| Gene Expression Regulation, Neoplastic | |
| HEK293 Cells | |
| Humans | |
| Lymphatic Metastasis | |
| Male | |
| Membrane Proteins | |
| Mice, Nude | |
| Mice, Transgenic | |
| Proto-Oncogene Proteins B-raf | |
| Wnt Signaling Pathway | |
| beta Catenin |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29990499 | EZH2 Inactivates Primary Cilia to Activate Wnt and Drive Melanoma. | https://conductscience.org/library/papers/29990499 |
Source PubMed
Cited by90
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42690564 | Primary cilia connect epithelial mesenchymal plasticity with anoikis resistance and cancer stemness. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42690564 | PubMed |
| 42374968 | Primary cilium disassembly - from mechanisms to roles in physiology and disease. | J Cell Sci | 2026 | https://conductscience.org/library/papers/42374968 | PubMed |
| 42220432 | EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives. | Oncol Res | 2026 | https://conductscience.org/library/papers/42220432 | PubMed |
| 42021201 | A novel mutation of IFT140 in a preschool child with Mainzer-Saldino syndrome accompanied by rare tumor blastic plasmacytoid dendritic cell neoplasm: a case report. | BMC Pediatr | 2026 | https://conductscience.org/library/papers/42021201 | PubMed |
| 41799498 | Combinational Inhibition of the eIF4F Complex, AKT1, and EZH2 Enhances Anticancer Effects in BRAFV600E Mutant A375 Melanoma Cells. | Oncol Res | 2026 | https://conductscience.org/library/papers/41799498 | PubMed |
| 41751164 | Use of Small-Molecule Inhibitors of CILK1 and AURKA as Cilia-Promoting Drugs to Decelerate Medulloblastoma Cell Replication. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751164 | PubMed |
| 41294104 | Primary cilia in cancer: structures, functions, mechanisms, and therapeutic implications. | Cancer Biol Med | 2025 | https://conductscience.org/library/papers/41294104 | PubMed |
| 41063628 | A novel murine model for sporadic, malignant peripheral nerve sheath tumors, driven by BrafV600E and Pten loss. | Dis Model Mech | 2025 | https://conductscience.org/library/papers/41063628 | PubMed |
| 40888126 | Taking Down the Primary Cilium: Pathways for Disassembly in Differentiating Cells. | Bioessays | 2025 | https://conductscience.org/library/papers/40888126 | PubMed |
| 40850308 | A methyl-to-acetyl switch in H3K27 drives metabolic reprogramming and resistance to BRAFV600E inhibition in melanoma. | Neoplasia | 2025 | https://conductscience.org/library/papers/40850308 | PubMed |
| 40017656 | Alteration of primary cilia and intraflagellar transport 20 (IFT20) expression in oral squamous cell carcinoma (OSCC) cell lines. | PeerJ | 2025 | https://conductscience.org/library/papers/40017656 | PubMed |
| 39984702 | Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/39984702 | PubMed |
| 39705308 | Permanent cilia loss during cerebellar granule cell neurogenesis involves withdrawal of cilia maintenance and centriole capping. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39705308 | PubMed |
| 39676858 | Immunomodulatory potential of primary cilia in the skin. | Front Immunol | 2024 | https://conductscience.org/library/papers/39676858 | PubMed |
| 39621784 | Melanocortin 1 receptor mediates melanin production by interacting with the BBSome in primary cilia. | PLoS Biol | 2024 | https://conductscience.org/library/papers/39621784 | PubMed |
| 39389955 | Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39389955 | PubMed |
| 39234399 | Primary cilia-associated signalling in squamous cell carcinoma of head and neck region. | Front Oncol | 2024 | https://conductscience.org/library/papers/39234399 | PubMed |
| 39121480 | Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers. | Cancer Discov | 2024 | https://conductscience.org/library/papers/39121480 | PubMed |
| 39113711 | SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/39113711 | PubMed |
| 38902533 | Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation. | Br J Cancer | 2024 | https://conductscience.org/library/papers/38902533 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| EZH2 | 2146 | PubTator's text mining | https://conductscience.org/library/genes/2146 | NCBI Gene |
| NRAS | 4893 | PubTator's text mining | https://conductscience.org/library/genes/4893 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30008323
GET https://conductscience.org/api/papers/v1/30008323/cited_by?page=2